top of page
Browse by category
Search


ACP issues new living clinical guideline on using weight loss medications
The American College of Physicians (ACP) has issued a new living clinical guideline to help physicians choose medications with lifestyle modifications to manage overweight and obesity in adults. The guideline, ‘Pharmacologic Treatments with Lifestyle Modifications in Nonpregnant Adults with Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline from the American College of Physicians’, was is published in Annals of Internal Medicine. More than half (59%) of


Alcohol absorption nearly doubles after bariatric surgery, improved patient education and awareness required
Researchers from the Norwegian University of Science and Technology (NTNU) have reported that patients who have bariatric surgery absorbs alcohol much more rapidly and patients need to know this when they choose the kind of surgery they will have. "Bariatric surgery can come with a price. Patients have a significantly higher risk of developing alcohol problems than if they did not undergo surgery," said Magnus Strømmen, a researcher at the Center for Obesity Research at St. O


GT Metabolic Solutions gains CE mark for GT Metabolic Magnet System
GT Metabolic Solutions has received CE certification (CE Mark) under the EU Medical Device Regulation (EU MDR) that enables commercialisation of the GT Metabolic Magnet System across the European Economic Area (EEA). GT Metabolic achieved successful review and certification of the GT Metabolic Magnet System for side-to-side enteroenterostomy (40mm, 50mm Magnets; throughout the small bowel) and gastroenterostomy (60mm, 70mm Magnets; stomach to small bowel), the first integrate


More than half of those who stop GLP-1s restart within a year
People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. "Our study asked two questions that haven't been well answered until now: How many people with type 2 diabetes taking GLP-1 medications actually stop using them? And how many restart them?" said Dr Sainikhil Sontha, a research associate at Boston University School of Public Health in Bost


Study strengthens the case for insurers and policymakers to support coverage and improve access to MBS
Metabolic and bariatric surgery (MBS) for teens with severe obesity is cost-effective over ten years, according to an analysis from Ann & Robert H Lurie Children's Hospital of Chicago, IL. While long-term clinical benefits of weight-loss surgery for eligible teens have been well established, and it is recommended by the American Academy of Pediatrics, insurance coverage has been limited and few teens can take advantage of the surgery. This study strengthens the case for insur


Organisations publish first-ever guideline on cardiovascular-kidney-metabolic syndrome
The American Heart Association, the American College of Cardiology, the American Diabetes Association, the Obesity Association and the American Society of Nephrology, have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic (CKM) syndrome, an interconnected set of health conditions that significantly increase the risk of multiorgan complications and adverse cardiovascular outcomes. The recommendations have been developed to help


Americans with severe obesity receive fewer surgeries despite rising need
A study led Pennington Biomedical researchers highlights growing disparities in standard surgical care access for individuals with extreme obesity and Americans with the highest levels of obesity are undergoing fewer surgical procedures overall. These procedures include common operations like knee or hip replacement, hernia surgery, and surgery of the breast, prostate and colon – operations that are frequently done to treat cancer. “Understanding and addressing these disparit


NBSR outcomes data demonstrates low mortality rate of metabolic and bariatric surgery in England
Publication of the latest data from the National Bariatric Surgical Registry (NBSR) has demonstrated that in-hospital survival from metabolic and bariatric surgery (MBS) is at least as good, if not better, than many common laparoscopic gastrointestinal procedures. Omar Khan Surgical data from metabolic and bariatric surgery (MBS) in England revealed an in-hospital mortality rate of 0.035% with three recorded in-hospital deaths from 8,454 procedures, between March 2023 and Apr


Wayne State University secures US patent for technology that detects and visualises arterial bleeding during surgeries
The United States Patent and Trademark Office (USPTO) has issued a new patent to Wayne State University and RediMinds that protects a technology that aims to detect and visualize arterial bleeding during surgeries. US Patent No. 12,635,098 B2 is titled, ‘Systems and Methods for Detecting, Localizing, Assessing and Visualizing Bleeding in a Surgical Field’ and recognises an inventive step forward in addressing intraoperative bleeding, a major complication of minimally invasive


Medtronic submits 510(k) filings to expand Hugo robotic-assisted surgery
Medtronic has announced significant milestones to unlock expanded indications for the Hugo robotic-assisted surgery (RAS) system in the US. The company has submitted 510(k) clearance for gynaecological surgery, general surgery indication including hernia repair, the LigaSure RAS Maryland instrument and for the ProGrip Advanced mesh for use in robotic-assisted ventral hernia repair. These milestones build momentum for Medtronic's Surgical business and its purposeful launch of
Browse by tag






bottom of page
